It has been found that skin cancer is the most common cancer in the age group of 15-34 and a new vaccine has been discovered to cure malignant melanoma, the deadliest type of skin cancer.

It has been established that skin cancer is associated with exposure to the sun on beach and the use of tanning booths.

A latest SCIBI vaccine targets tumor cells, and found to be successful in treating this disease believed by Lindy Durrant, professor in clinical oncology at the Nottingham University School of Molecular Medical Sciences.

This vaccine comprises of DNA and genetic materials from tumors and the body's own natural defence systems get activated by this vaccine.

Melanoma is the type of cancer which affects the immunity of cells and this vaccine specifically targets these cells only leaving healthy cells untouched.

Durrant said that till date malignant melanoma can be treated successfully only when it is detected early. It can be treated by completely removing the skin melanoma by surgery.

Researchers said that in cases where it is not detected earlier, chemotherapy and radiotherapy are the methods to cure it but unfortunately they are not producing good results.

Durrant further said that it is very early stage to claim the integrity of this vaccine but if patients show same results as were observed in lab then it's going to be a great revolution in curing patients from skin cancers.

The information was released to create awareness among the people about the clinical trials for the SCIBI vaccine which are due to begin soon at Nottingham City Hospital and at centers in Manchester and Newcastle.

Earlier, researchers recommended that this vaccine would be given to the patients suffering from acute malignant melanoma, in which it is spread to other parts of the body.